A new discovery could play an important role in establishing which bowel cancer patients are most likely to require chemotherapy.
The discovery is based around a protein called FOXO3. Scientists have discovered that patients with low levels of the protein have an increased risk of their cancer spreading to other parts of the body. Such patients are deemed ‘most at risk’ and probably require chemotherapy.
New marker for bowel cancer
Source: Digital Journal
Image credit: Creative Commons - Attribution-ShareAlike
Art and Science of Laboratory Medicine